Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 14;10(4):613.
doi: 10.3390/vaccines10040613.

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice

Affiliations

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice

Liat Bar-On et al. Vaccines (Basel). .

Abstract

Longevity of the immune response following viral exposure is an essential aspect of SARS-CoV-2 infection. Mild SARS-CoV-2 infection of K18-hACE2 mice was implemented for evaluating the mounting and longevity of a specific memory immune response. We show that the infection of K18-hACE2 mice induced robust humoral and cellular immunity (systemic and local), which persisted for at least six months. Virus-specific T cells and neutralizing antibody titers decreased over time, yet their levels were sufficient to provide sterile immunity against lethal rechallenge six months post-primary infection. The study substantiates the role of naturally induced immunity against SARS-CoV-2 infection for preventing recurring morbidity.

Keywords: COVID-19; K18-hACE2 mice; SARS-CoV-2; mild infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Humoral and cellular-specific immune response after mild SARS-CoV-2 infection. K18-hACE2 mice were infected with SARS-CoV-2 (80 PFU/mouse, i.n.) 24 weeks (blue), 12 weeks (green) or 3 weeks (red) prior to their simultaneous analysis and challenge. Sera, spleen and lung samples were collected at the indicated time points for the evaluation of SARS-CoV-2-specific humoral (B,C) and cellular (D) responses, as describe in Materials and Methods. (A) Schematic representation of experimental design. (B) SARS-CoV-2 RBD-specific IgG antibodies in the serum of the 3 groups prior to the challenge, determined by ELISA. (C) NT50 titers determined by the Plaque Reduction Neutralization test (PRNT). (D) SARS-CoV-2-specific cellular response determined by ELISpot in the lungs (left panel) and spleen (right panel). Each symbol represents one mouse. p-values indicate significant differences (* p < 0.05; ** p < 0.005; *** p < 0.0005; **** p < 0.0001).
Figure 2
Figure 2
Protective efficacy against SARS-CoV-2 reinfection. K18-hACE2 mice from the 3 groups, as indicated (see Figure 1A, n = 20 for each group), were reinfected i.n. with 3 × 104 PFU SARS-CoV-2. Control group consisted of naïve animals (n = 15). Animals were monitored daily for body weight (A) and survival (B). Five mice from each group were sacrificed at day 2 and 4 post-challenge. SARS-CoV-2 loads in the lungs (C) and brain (D) were determined by a PFU assay. Data points represent the virus load of each animal; the horizontal bar indicates the mean of each group. The dashed line indicates the lower limit of detection. Statistical analysis was performed with the log-rank (Mantel–Cox) test for survival data.

References

    1. Yamayoshi S., Yasuhara A., Ito M., Akasaka O., Nakamura M., Nakachi I., Koga M., Mitamura K., Yagi K., Maeda K., et al. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. EClinicalMedicine. 2021;32:100734. doi: 10.1016/j.eclinm.2021.100734. - DOI - PMC - PubMed
    1. Grau-Expósito J., Sánchez-Gaona N., Massana N., Suppi M., Astorga-Gamaza A., Perea D., Rosado J., Falco A., Kirkegaard C., Torrella A., et al. Peripheral and lung resident memory T cell responses against SARS-CoV-2. Nat. Commun. 2021;12:3010. doi: 10.1038/s41467-021-23333-3. - DOI - PMC - PubMed
    1. Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., Grifoni A., Ramirez S.I., Haupt S., Frazier A., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371:eabf4063. doi: 10.1126/science.abf4063. - DOI - PMC - PubMed
    1. Rodda L.B., Netland J., Shehata L., Pruner K.B., Morawski P.A., Thouvenel C.D., Takehara K.K., Eggenberger J., Hemann E.A., Waterman H.R., et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. Cell. 2021;184:169–183. doi: 10.1016/j.cell.2020.11.029. - DOI - PMC - PubMed
    1. Long Q.X., Jia Y.J., Wang X., Deng H.J., Cao X.X., Yuan J., Fang L., Cheng X.-R., Luo C., He A.-R., et al. Immune memory in convalescent patients with asymptomatic or mild COVID-19. Cell Discov. 2021;7:18. doi: 10.1038/s41421-021-00250-9. - DOI - PMC - PubMed

LinkOut - more resources